产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 20476 | AZD5718 | 2041075-86-7 | 98% Min. |  |
| AZD5718 is a novel Inhibitor of 5-Lipoxygenase Activating Protein(FLAP) for Treatment | ||||
| 20450 | ALZ-801 | 1034190-08-3 | 98% Min. |  |
| ALZ-801 is an oral, small-molecule inhibitor of beta amyloid (Aβ) oligomer formation | ||||
| 20440 | AZD-2207 | 866598-45-0 | 98% Min. |  |
| AZD-2207 is a cannabinoid receptor CB1 antagonist and highly lipophilic compound for | ||||
| 20439 | AZD6703 | 851845-37-9 | 98% Min. |  |
| AZD6703 is a potent, selective and reversible orally bioavailable inhibitor of p38 mi | ||||
| 20429 | Afizagabar | 1398496-82-6 | 98% Min. |  |
| Afizagabar, also known as S44819 and Egis 13529, is a GABA receptor antagonist. | ||||
| 20427 | N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺 | 558447-26-0 | 98% Min. |  |
| 171453 | 1-(6-氨基吡啶-2-基)乙-1-酮 | 1060801-23-1 | ≧98.0% |  |
| 1-(6-氨基吡啶-2-基)乙-1-酮, CAS 1060801-23-1. | ||||
| 171553 | Anle138b | 882697-00-9 | ≧98.0% |  |
| Anle138b 是一种口服的、可透过血脑屏障的蛋白质抑制剂。在 α-突 | ||||
| 20425 | 2-吗啉基-3-溴-5-氨基吡啶 | 1215932-56-1 | 98% Min. |  |
| 20424 | 2-氨基-5-溴-3-氰基-4-甲氧基吡啶 | 951884-75-6 | 98% Min. |  |
| 20421 | 4-氨基-6-碘嘧啶 | 53557-69-0 | 98% Min. |  |
| 20415 | 2 - ((2-(叔丁基)苯基)氨基)-2-氧代乙酸 | 254751-08-1 | 98% Min. | phenyl]aMino]-2-oxo-_254751-08-1.png) |
| 20413 | (Z)-1-(1-苯乙烷)氨基脲 | 2492-30-0 | 98% Min. |  |
| 20400 | 2-氨基-4-(4-氟苯基)-1,3-噻唑-5-腈 | 952753-59-2 | 98% Min. | thiazole-5-carbonitrile_952753-59-2.png) |
| 20397 | 7-碘吡咯并[2,1-F][1,2,4]三嗪-4-胺 | 1770840-43-1 | 98% Min. |  |
| 20389 | 2-Amino-6-fluoro-3-nitropyridine | 60186-21-2 | 98% Min. |  |
| G20382 | 4-Aza-1-azoniabicyclo[2.2.2]octane, 1,1'-(1,12-dodecanediyl)bis-, dibromide (9CI) | 256448-15-4 | 98% Min. |  |
| 1711223 | Asciminib HCl (盐酸盐) | 2119669-71-3 | ≧98.0% |  |
| Asciminib，也称为 ABL001，是一种有效的 BCR-ABL 变构抑制剂。 | ||||
| 226191 | AGN 196996 | 958295-17-5 | ≧98.0% |  |
| AGN 196996 是一种有效的选择性 RARα 拮抗剂，Ki 值为 2 nM；对 RARβ（ | ||||
| 20319 | Ablukast | 96566-25-5 (free acid) | 98% Min. | |
| Ablukast is a leuktriene receptor antagonist that acts as an anti-asthmatic. | ||||
| 20312 | 2-氨基-5-三氟甲基苯甲酸 | 83265-53-6 | 98% Min. |  |
| 20303 | Afabicin | 1518800-35-5 | 98% Min. |  |
| Afabicin (formerly Debio 1450, AFN-1720) is a prodrug of afabicin desphosphono, an en | ||||
| 20300 | Acoramidis (AG-10 ) | 1446711-81-4 | ≧98.0% | _1446711-81-4.png) |
| Acoramidis (formerly AG10) is an investigational, orally-administered small molecule | ||||
| 20298 | ASTX-029 | 2095719-92-7 | 98% Min. |  |
| ASTX029 is a highly potent and selective dual-mechanism ERK inhibitor. ASTX029 inhibi | ||||
| 20297 | AZD-4818 | 1003566-93-5 | 98% Min. |  |
| AZD-4818 is a chemokine CCR1 antagonist that is used for the treatment of chronic obs | ||||
| 20289 | Adavivint | 1467093-03-3 (free base) | 98% Min. | |
| 20286 | A2793 | 88349-90-0 | 98% Min. |  |
| A2793 is an inhibitor of TRESK (IC50 value of 6.8 μM for mTRESK). A2793 inhibited TW | ||||
| 20281 | ABT-384 | 868623-40-9 | ≧98.0% |  |
| ABT-384 是 11β-羟基类固醇脱氢酶 1 (HSD-1) 的有效选择性抑制剂，该 | ||||
| 20269 | AN 0128 | 872044-70-7 | 98% Min. |  |
| AN 0128, also known as CRM-0005 and ONT-0001, is a tumour necrosis factor alpha (TNF- | ||||
| 20267 | Almonertinib | 1899921-05-1 | 98% Min. |  |
| Almonertinib is an orally available inhibitor of the epidermal growth factor receptor | ||||